Literature DB >> 26154571

The Impact of Magnetic Resonance Imaging on Prediction of Extraprostatic Extension and Prostatectomy Outcome in Patients with Low-, Intermediate- and High-Risk Prostate Cancer: Try to Find a Standard.

Jan Philipp Radtke1,2, Boris A Hadaschik1, Maya B Wolf2, Martin T Freitag2, Constantin Schwab1, Celine Alt3, Wilfried Roth4, Stefan Duensing1, Sascha A Pahernik1, Matthias C Roethke2, Heinz-Peter Schlemmer2, Markus Hohenfellner1, Dogu Teber1.   

Abstract

PURPOSE: To investigate the value of multiparametric magnetic resonance imaging (mpMRI) and to predict extracapsular extension (ECE), seminal vesicle (SV) infiltration, and a negative surgical margin (SM) status at radical prostatectomy (RP) for different prostate cancer (PC) risk groups. PATIENTS AND METHODS: In the study, 805 men underwent 3 tesla mpMRI without endorectal coil before MRI/transrectal ultrasonography-fusion guided prostate biopsy. MRIs were analyzed using the prostate imaging reporting and data system. The cohort was classified into risk groups according to National Comprehensive Cancer Network (NCCN) criteria. Of 132 men who subsequently underwent RP, pathologic stage and SM status at RP were used as reference. Retrospectively, we investigated a European Society of Urogenital Radiology (ESUR) score for ECE and SV-infiltration. Statistical analyses included regression analyses, receiver operating characteristics (ROC), and Youden Index to assess an ESUR-score cutoff.
RESULTS: Area under the curve in ROC curve analyses was 0.82 for ESUR-ECE score to detect pT(3a)-disease and 0.77 for ESUR-SV score for pT(3b). Using a cutoff of 4 for ECE and of 2 for SV, the positive predictive value of the ECE-score for harboring pT(3) was 50.0%, 90.0%, and 88.8% for the low-, intermediate- and high-risk cohort. Retrospectively, the use of the ESUR-ECE score preoperatively would have changed the initial surgical plan, according to NCCN criteria, in 31.1% of patients. In the high-risk subgroup, 9/35 (25.7%) patients were correctly assessed as not harboring pT(3) by imaging (ECE score <4), and would have allowed secure robot-assisted radical prostatectomy and nerve-sparing surgery (NSS). When T3 suspicion on preoperative MRI would be taken into account, intraoperative frozen-sections (IFS) might avoid positive SM in 12/18 high-risk patients and an oncologic secure NSS in 8/20 intermediate-risk patients.
CONCLUSION: Prediction of pT(3) disease is crucial to plan NSS and to achieve negative SM in RP. Standardized ECE scoring on mpMRI is an independent predictor of pT(3) and may help to plan RP with oncologic security, even in high-risk patients. In addition, it allows more accurate selection of a subgroup of patients for systematic and MRI-guided IFS.

Entities:  

Mesh:

Year:  2015        PMID: 26154571     DOI: 10.1089/end.2015.0358

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  9 in total

1.  Complete bladder neck preservation promotes long-term post-prostatectomy continence without compromising midterm oncological outcome: analysis of a randomised controlled cohort.

Authors:  Joanne N Nyarangi-Dix; Diana Tichy; Gencay Hatiboglu; Sascha Pahernik; Georgi Tosev; Markus Hohenfellner
Journal:  World J Urol       Date:  2017-12-06       Impact factor: 4.226

2.  Simultaneous whole-body 18F-PSMA-1007-PET/MRI with integrated high-resolution multiparametric imaging of the prostatic fossa for comprehensive oncological staging of patients with prostate cancer: a pilot study.

Authors:  Martin T Freitag; Claudia Kesch; Jens Cardinale; Paul Flechsig; Ralf Floca; Matthias Eiber; David Bonekamp; Jan P Radtke; Clemens Kratochwil; Klaus Kopka; Markus Hohenfellner; Albrecht Stenzinger; Heinz-Peter Schlemmer; Uwe Haberkorn; Frederik Giesel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-10-16       Impact factor: 9.236

Review 3.  [Multimodal therapy of locally advanced prostate cancer].

Authors:  A Heidenreich; D Böhmer
Journal:  Urologe A       Date:  2016-03       Impact factor: 0.639

4.  A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.

Authors:  Sherif Mehralivand; Joanna H Shih; Stephanie Harmon; Clayton Smith; Jonathan Bloom; Marcin Czarniecki; Samuel Gold; Graham Hale; Kareem Rayn; Maria J Merino; Bradford J Wood; Peter A Pinto; Peter L Choyke; Baris Turkbey
Journal:  Radiology       Date:  2019-01-22       Impact factor: 11.105

5.  Multi-parametric MRI of the prostate: Factors predicting extracapsular extension at the time of radical prostatectomy.

Authors:  Geoffrey S Gaunay; Vinay Patel; Paras Shah; Daniel Moreira; Ardeshir R Rastinehad; Eran Ben-Levi; Robert Villani; Manish A Vira
Journal:  Asian J Urol       Date:  2016-11-19

6.  Clinical utility of MRI in the decision-making process before radical prostatectomy: Systematic review and meta-analysis.

Authors:  Mieszko Kozikowski; Wojciech Malewski; Wojciech Michalak; Jakub Dobruch
Journal:  PLoS One       Date:  2019-01-07       Impact factor: 3.240

7.  Prostate specific membrane antigen-radio guided surgery using Cerenkov luminescence imaging-utilization of a short-pass filter to reduce technical pitfalls.

Authors:  Boris Alexander Hadaschik; Stephan Tschirdewahn; Christopher Darr; Pedro Fragoso Costa; Claudia Kesch; Ulrich Krafft; Lukas Püllen; Nina Natascha Harke; Jochen Hess; Tibor Szarvas; Johannes Haubold; Henning Reis; Wolfgang Peter Fendler; Ken Herrmann; Jan Philipp Radtke
Journal:  Transl Androl Urol       Date:  2021-10

Review 8.  Selection of patients for nerve sparing surgery in robot-assisted radical prostatectomy.

Authors:  André N Vis; Roderick C N van den Bergh; Henk G van der Poel; Alexander Mottrie; Philip D Stricker; Marcus Graefen; Vipul Patel; Bernardo Rocco; Birgit Lissenberg-Witte; Pim J van Leeuwen
Journal:  BJUI Compass       Date:  2021-11-09

9.  The efficacy and utilisation of preoperative multiparametric magnetic resonance imaging in robot-assisted radical prostatectomy: does it change the surgical dissection plan?

Authors:  Hasan Hüseyin Tavukçu; Ömer Aytaç; Numan Cem Balcı; Haluk Kulaksızoğlu; Fatih Atuğ
Journal:  Turk J Urol       Date:  2017-12-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.